Lemtrada Better At Preventing MS Relapses Than Rebif, But Not At Reducing Disability Risk
Links shared publicly online about this topic.
- 154total visits
Lemtrada Better At Preventing MS Relapses Than Rebif, But Not At Reducing Disability Risk
Although Lemtrada (alemtuzumab) was found to be more effective in preventing MS relapses than the older drug - Rebif - it did not prevent multiple sclerosis (MS) from becoming disabling in a late-
View full resource at medicalnewstoday.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Disability, Rebif, Preventing
Most Recently Shared on July 12, 2011 at 11:29 pm By:
Lemtrada Better At Preventing MS Relapses Than Rebif, But Not At Reducing Disability Risk: Although Lemtrada (al... http://bit.ly/opFSrI
Also Shared By:
Advertisement
MNT Multiple Scl
@mnt_multiplescl
Lemtrada Better At Preventing MS Relapses Than Rebif, But Not At Reducing Disability Risk http://mnt.to/3Y8Z #multiplesclerosis
1 year ago...